The effects of intranasal and iv administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2
Abstract. A SYNTHETIC hexapeptide,
(GHRP) was generated by a combination of conformational energy calculations and testing of GH-releasing activity [1] .This peptide has been shown to stimulate GH release in vivo as well as in vitro in a variety of animal species [2] [3] [4] [5] [6] . Particularly in humans, GHRP was found to be a very potent GH-releasing agent [7, 8] .
Though the mechanism by which GHRP stimulates GH release has not yet been fully clarified, GHRP may be useful as a therapeutic and/or diagnostic agent in clinical practice. Since GHRP is a small molecule, it is expected to be easily absorbed from the nasal mucosa. The route of intranasal administration will be less injurious and more acceptable than iv, im or sc injection for chronic treatment, particularly in children. In this study we compared the plasma GH responses to GHRP in intranasal administration and iv injection in normal men. The effect of repetitive intranasal administration on the plasma IGF-I level was also examined in the same subjects. although a part of GHRH-LI in peripheral blood is known to be derived from the hypothalamus [11] . The present findings suggest the usefulness of GHRP as a therapeutic agent in some GHdeficient short children, particularly in patients in which hypothalamic impairment is a cause. When considering the age of patients and the period of treatment, the intranasal route of administration for GHRP will be more acceptable than injection.
